Second Circuit Upholds Dismissal Of AstraZeneca Investor Suit
Second Circuit Upholds Dismissal of AstraZeneca Investor Suit; Southern District of New York Dismisses Stockholder Suit Against Array Technologies; Eastern District of New York Tosses Stockholder Class Action Based on Ericsson Bribery Investigation
Second Circuit Upholds Dismissal of AstraZeneca Investor Suit
On May 16, 2023, the US Court of Appeals for the Second Circuit affirmed the Southern District of New York’s order dismissing an action brought by investors of AstraZeneca PLC (AstraZeneca) attempting to hold the company liable for alleged […]